Fang-Ting Chiu

Title: The Innovations of Fang-Ting Chiu

Introduction

Fang-Ting Chiu is a notable inventor based in Union City, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cardiovascular diseases. With a total of 3 patents to his name, Chiu's work reflects a commitment to advancing medical science.

Latest Patents

Chiu's latest patents include a method for treating cardiovascular disease with calcium channel compounds. These compounds are defined by the formula ##STR1## wherein R.sub.1 and R.sub.2 are each independently --H or lower alkoxy. Another significant patent involves tetrahydroisoquinoline derivatives, which are characterized by the formula ##STR1## where R.sub.1 and R.sub.2 are each independently --H or lower alkoxy, and R.sub.3 and R.sub.4 are each independently lower alkyl. Additionally, R.sub.5 and R.sub.6 can be --OCH.sub.3, or together form --OCH.sub.2 O-- or --OCH.sub.2 CH.sub.2 O--, along with pharmaceutically acceptable acid addition salts prepared by cyclizing, deoxygenating, coupling, or hydrogenating the intermediates disclosed.

Career Highlights

Chiu is currently associated with Syntex (U.S.A.) Inc., where he continues to innovate and develop new pharmaceutical solutions. His work has been instrumental in addressing critical health issues, particularly in cardiovascular treatment.

Collaborations

Chiu has collaborated with notable colleagues such as Robin D. Clark and Joseph M. Muchowski, contributing to a dynamic research environment that fosters innovation.

Conclusion

Fang-Ting Chiu's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator in medical science. His work continues to pave the way for advancements in the treatment of cardiovascular diseases.